MAUREEN PLACE: Open Payments
NPI 1407337322 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $594 |
| Novo Nordisk Inc | 2 | $205 |
| Lilly USA, LLC | 2 | $143 |
| GlaxoSmithKline, LLC. | 1 | $109 |
| Amneal Pharmaceuticals LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $15 |
Products named: VRAYLAR, ZEPBOUND, AREXVY, Ozempic, Wegovy, REXULTI, UNITHROID, MOUNJARO.
Industry payments across RI — which companies pay providers there.
